Cargando…
Gabapentin use, abuse, and the US opioid epidemic: the case for reclassification as a controlled substance and the need for pharmacovigilance
The abuse potential of gabapentin is well documented; with gabapentin having been noted as an agent highly sought after for use in potentiating opioids. When combined with opioids, the risk of respiratory depression and opioid-related mortality increases significantly. In the US, gabapentin was appr...
Autores principales: | Peckham, Alyssa M, Ananickal, Maria J, Sclar, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103607/ https://www.ncbi.nlm.nih.gov/pubmed/30154674 http://dx.doi.org/10.2147/RMHP.S168504 |
Ejemplares similares
-
Diagnoses of Cardiovascular Disease or Substance Addiction/Abuse in US Adults Treated for ADHD with Stimulants or Atomoxetine: Is Use Consistent with Product Labeling?
por: Fairman, Kathleen A., et al.
Publicado: (2018) -
The need for greater opioid pharmacovigilance in COPD
por: Vozoris, Nicholas T
Publicado: (2017) -
Substance abuse and rehabilitation: responding to the global burden of diseases attributable to substance abuse
por: Wu, Li-Tzy
Publicado: (2010) -
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
por: Baldo, Paolo, et al.
Publicado: (2018) -
Monitoring of substance abuse in India – Initiatives & experiences
por: Ray, Rajat, et al.
Publicado: (2012)